Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 6 days ago

      Eli Lilly’s popular weight loss drug Zepbound has joined its competitor, Novo Nordisk’s Wegovy, in officially being hit by a shortage. The Food and Drug Administration said ...

    • Gateway - Quartz

      Quartz· 6 days ago

      Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma ...